Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & ISI's SCI  
Users online: 5180  
Home | Subscribe | Feedback | Login 
About Latest Articles Back-Issues Article Submission Resources Sections Etcetera Contact
 
Read this article

 


    Article Cited by others

REVIEW ARTICLE

Biological agents in rheumatoid arthritis

Shankar S, Handa Rohini

Year : 2004| Volume: 50| Issue : 4 | Page no: 293-299

   This article has been cited by
 
1 Shared experiences and best practices in the management of rheumatoid arthritis and Crohnæs disease
Kavanaugh, A.F., Mayer, L.F., Cush, J.J., Hanauer, S.B.
American Journal of Medicine. 2011; 124(4 suppl): e 1-e 18
[Pubmed]  [Google Scholar]
2 Rabeximod reduces arthritis severity in mice by decreasing activation of infl ammatory cells
Hultqvist, M., Nandakumar, K.S., Björklund, U., Holmdahl, R.
Annals of the Rheumatic Diseases. 2010; 69(8): 1527-1532
[Pubmed]  [Google Scholar]
3 Rituximab: Use in rheumatoid arthritis
Richter, J., Van Der Merwe, E.
SA Pharmaceutical Journal. 2009; 76(2): 32-37
[Pubmed]  [Google Scholar]
4 Biologicals in the treatment of rheumatoid arthritis | [Agentes biológicos na artrite reumatoide]
Carvalho Jr., F.F., Suehiro, R.M., Golmia, R., Scheinberg, M.
Revista Brasileira de Medicina. 2009; 66((1-2)): 20-27
[Pubmed]  [Google Scholar]
5 Abatacept - Trade name: Orencia | [Abatacept Handelsname: Orencia (D, A, CH)]
Alten, R., Dettbarn, E.
Tagliche Praxis. 2009; 50(4): 835-838
[Pubmed]  [Google Scholar]
6 Abatacept - Trade name: Orencia | [Abatacept. Handelsname: Orencia (D, A, CH)]
Alten, R., Dettbarn, E.
Internistische Praxis. 2009; 49(4): 835-838
[Pubmed]  [Google Scholar]
7 IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: Results from a 24-week multicentre randomised placebo-controlled trial
Emery, P., Keystone, E., Tony, H.P., Cantagrel, A., Van Vollenhoven, R., Sanchez, A., Alecock, E., (...), Kremer, J.
Annals of the Rheumatic Diseases. 2008; 67(11): 1516-1523
[Pubmed]  [Google Scholar]
8 Cyclophilin A up-regulates MMP-9 expression and adhesion of monocytes/ macrophages via CD147 signalling pathway in rheumatoid arthritis
Yang, Y., Lu, N., Zhou, J., Chen, Z.-N., Zhu, P.
Rheumatology. 2008; 47(9): 1299-1310
[Pubmed]  [Google Scholar]
9 The change of taurine transport in osteocytes by oxidative stress, hypertonicity and calcium channel blockers
Kang, Y.-S., Kim, S.-J.
Biomolecules and Therapeutics. 2008; 16(3): 219-225
[Pubmed]  [Google Scholar]
10 Absence of In vitro responses to type II collagen by splenocytes from arthritic BALB/c mice is possibly caused by intrinsic CD25(+) regulatory cells
Backstrom F, Dahlgren U
SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2008; 67(4): 362-369
[Pubmed]  [Google Scholar]
11 T cells regulate initial inflammatory responses during acute infection
Jie Z, Xuan-Ming Y, Du PS, et al.
PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS. 2008; 35(2): 129-132
[Pubmed]  [Google Scholar]
12 MK2: a novel molecular target for anti-inflammatory therapy
Duraisamy S, Bajpai M, Bughani U, et al.
EXPERT OPINION ON THERAPEUTIC TARGETS. 2008; 12(8): 921-936
[Pubmed]  [Google Scholar]
13 The recombinant humanized anti-IL-6 receptor antibody tocilizumab, an innovative drug for the treatment of rheumatoid arthritis
Ohsugi Y, Kishimoto T
EXPERT OPINION ON BIOLOGICAL THERAPY. 2008; 8(5): 669-681
[Pubmed]  [Google Scholar]
14 Inhibition of TNF alpha does not induce viral reactivation in patients with chronic hepatitis C infection: two cases
Aslanidis S, Vassiliadis T, Pyrpasopoulou A, et al.
CLINICAL RHEUMATOLOGY. 2007; 26 (2): 261-264
[Pubmed]  [Google Scholar]
15 Radiation synovectomy using 188Re-tin colloid improves knee synovitis as shown by MRI in refractory rheumatoid arthritis
Shin K, Lee JC, Choi HJ, et al.
NUCLEAR MEDICINE COMMUNICATIONS. 2007; 28 (4): 239-244
[Pubmed]  [Google Scholar]
16 Inflammatory caspases: Targets for novel therapies
Cornelis, S., Kersse, K., Festjens, N., Lamkanfi, M., Vandenabeele, P.
Current Pharmaceutical Design. 2007; 13(3): 365-383
[Pubmed]  [Google Scholar]
17 Inflammatory caspases: Targets for novel therapies
Cornelis, S., Kersse, K., Festjens, N., Lamkanfi, M., Vandenabeele, P.
Current Pharmaceutical Design. 2007; 13(4): 367-385
[Pubmed]  [Google Scholar]
18 Rheumatoid Arthritis and the Skin
Sarzi-Puttini, P., Atzeni, F., Carrabba, M.
Handbook of Systemic Autoimmune Diseases. 2006; 5: 161-183
[Pubmed]  [Google Scholar]
19 The modulatory effects of the volatile oil of ginger on the cellular immune response in vitro and in vivo in mice
Zhou HL, Deng YM, Xie QM
JOURNAL OF ETHNOPHARMACOLOGY. 2006; 105 ((1-2)): 301-305
[Pubmed]  [Google Scholar]
20 Interleukin-17, a regulator of angiogenic factor release by synovial fibroblasts
Honorati MC, Neri S, Cattini L, et al.
OSTEOARTHRITIS AND CARTILAGE. 2006; 14 (4): 345-352
[Pubmed]  [Google Scholar]
21 Anti-TNF-alpha antibody therapies in autoimmune diseases
Chatzantoni K, Mouzaki A
CURRENT TOPICS IN MEDICINAL CHEMISTRY. 2006; 6 (16): 1707-1714
[Pubmed]  [Google Scholar]
22 Cyclophilin A may contribute to the inflammatory processes in rheumatoid arthritis through induction of matrix degrading enzymes and inflammatory cytokines from macrophages
Kim H, Kim WJ, Jeon ST, Koh EM, Cha HS, Ahn KS, Lee WH
CLINICAL IMMUNOLOGY. 2005; 116 (3): 217-224
[Pubmed]  [Google Scholar]

 

Online since 12th February '04
© 2004 - Journal of Postgraduate Medicine
Official Publication of the Staff Society of the Seth GS Medical College and KEM Hospital, Mumbai, India
Published by Wolters Kluwer - Medknow